EXC - Exelon Corp
Executive Summary
Exelon Corporation is a US regulated electric holding company headquartered in Chicago, Illinois, formed in 1999. It serves residential, commercial, industrial, public authority, and electric railroad customers through regulated distribution and transmission operations across multiple service territories, and it ranks among the largest pure-play regulated electric utilities in the United States by rate base and customer count. The company has a market capitalisation of approximately USD 45.96 billion and a current price of USD 40.73, sitting roughly 20% below its 52-week high of USD 50.65 and only marginally above its 52-week low of USD 39.73.
The investment case rests on a multi-year, transmission-focused capital programme designed to earn regulated returns, a reaffirmed earnings trajectory from management, and a forward P/E of 14.92 that screens as undemanding for a regulated utility. The key near-term catalyst is the next scheduled earnings release, with the most recent reported quarter having been released on 30 July 2026; the subsequent reporting date should be monitored via the company's investor relations calendar. The primary risk is that ongoing regulatory matters, which have already required non-GAAP adjustments in prior reconciliations, could weigh on permitted returns and rate-base growth.
Bottom line: BUY. Conviction Score: 67/100. The view would be upgraded to a stronger buy on a clear, named rate-case win or a step-change in transmission project awards, and downgraded on an adverse regulatory order that materially reduces allowed return on equity or impairs the capital plan.
Bottom line - OPPORTUNISTIC BUY at 64/100. Not currently actionable.
Thesis break: An adverse regulatory ruling from a principal state commission or FERC that materially reduces allowed ROE, a cancellation or material delay of named transmission projects underpinning the capital plan, or a substantial acceleration of equity issuance beyond the USD 1.5 billion remaining under the 2025 Equity Distribution Agreement.
Business Model
Exelon generates substantially all of its revenue from regulated electric activities, principally the delivery (distribution) and high-voltage transmission of electricity to end customers in its service territories. Following earlier portfolio reshaping, the company operates as a regulated electric-focused holding company, and its consolidated revenue mix is dominated by distribution tariff sales to retail customers, transmission service revenues recovered through regional transmission organisation (RTO) mechanisms, and a smaller contribution from other regulated activities. The July 2026 quarterly print of USD 0.43 EPS versus USD 0.49 expected indicates the typical narrow earnings variance characteristic of regulated returns, where rate-base growth and allowed ROE drive most of the operating result rather than commodity price exposure.
Customers are spread across four principal segments: residential households, commercial businesses, industrial users, and public authorities including electric railroad accounts, consistent with the company's SEC filings. Because generation margins are largely passed through or hedged under regulated constructs, competitive advantage is not derived from commodity trading or retail marketing but from scale of rate base, geographic diversity across multiple state regulatory jurisdictions, and access to FERC-regulated transmission projects. This structure produces predictable cash flows and supports the company's status as a dividend-paying utility, with the trailing yield reported at 3.59% as of mid-2026.
The principal competitive moat is regulatory rather than market-based. Multi-state rate-base exposure smooths individual commission outcomes, while the transmission capital programme provides a queue of projects recoverable under FERC formula rates, reducing earnings sensitivity to any single state commission. The trade-off is that returns are capped at regulator-set ROE levels and growth is capital-intensive, requiring continued equity issuance - the company has used its at-the-market programme to fund deployment, with USD 1.5 billion of common stock remaining available for sale under the 2025 Equity Distribution Agreement as of 31 December 2025.
Financial Snapshot
Recent Catalysts
[30 July 2026] - Exelon reported second-quarter 2026 earnings of USD 0.43 per share, missing the USD 0.49 consensus estimate. The result is the most recent datapoint on the company's earnings trajectory and frames the next quarter's guidance discussion. Source: public.com EXC earnings page (referencing the 30 July 2026 release).
[25 August 2026] - Exelon filed a Form 8-K with the SEC (Commission File Number 001-16169) for an event dated 25 August 2026, with a corresponding EX-99.1 investor or media exhibit referencing the company contact Omar Tewfik (media line 312-394-7417). The substantive content of the filing should be verified directly on EDGAR. Source: SEC EDGAR Form 8-K filed 25 August 2026 (exc-20260825 / exc-20260825ex991).
[10 August 2026] - Trailing total return data published on 10 August 2026 showed that Exelon's total return had lagged the S&P 500, indicating soft relative performance despite stable underlying earnings. The data point is the most recent return reference available in the public sources reviewed. Source: Yahoo Finance EXC quote page (trailing total returns as of 10 August 2026).
[12 February 2026] - The Exelon Form 10-K for the year ended 31 December 2025 was filed on 12 February 2026, disclosing that USD 1.5 billion of common stock remained available for sale under the 2025 Equity Distribution Agreement at year-end 2025 and that 23.6 million shares with USD 979 million of net proceeds had been issued under related programmes during 2023 through 2025. Source: SEC EDGAR Form 10-K filed 12 February 2026, Item 1A and Note 17.
Thesis Evaluation
Bull Case (36% weight)
Transmission project awards accelerate beyond the current capital plan, regulatory commissions authorise constructive rate-case outcomes, and allowed ROE holds at or above current levels, driving EPS growth above the rate-base growth rate. With the dividend yield at 3.59% and a forward P/E re-rating toward 17-18x on demonstrated delivery, a 12-month price target of $48 is reasonable, representing roughly 18% upside plus a carry from the dividend.
Base Case (48% weight)
Earnings continue on a stable trajectory in line with reaffirmed guidance, the capital programme is funded by a mix of internally generated cash flow and measured ATM issuance, and the regulatory matters line item remains a non-GAAP adjustment without a fundamental hit to allowed returns. On a 12-month view, EPS grows in line with rate base and the multiple holds near the current 14.92x P/E, supporting a 12-month price target of $44, modestly above the current USD 40.73 print and consistent with a mid-single-digit total return once the 3.59% yield is included.
Bear Case (16% weight)
An adverse regulatory order, a deterioration in one or more state commission outcomes, or a material unfavourable resolution of the regulatory matters line item reduces allowed ROE or impairs the capital plan, while ATM dilution continues at the 2023-2025 pace. EPS growth slows below rate-base growth and the multiple de-rates toward 13x, giving a 12-month downside target of $36, roughly 12% below the current price before dividend considerations.
Key Risks
- Ongoing regulatory matters and non-GAAP adjustments: Regulatory proceedings disclosed in the company's earnings reconciliations have already required non-GAAP adjustments and could produce further adverse rulings that compress allowed returns or delay rate-base recovery. Estimated probability: 35%. Impact: moderate.
- Continued equity issuance under the ATM programme: The 2025 Equity Distribution Agreement had USD 1.5 billion of common stock remaining available for sale at 31 December 2025, following USD 979 million of issuance across 2023-2025, creating ongoing dilution risk if the capital programme is funded predominantly through equity. Estimated probability: 70%. Impact: low.
- Interest-rate sensitivity and capital cost: As a capital-intensive regulated utility, Exelon's funding cost is sensitive to Treasury yields, and a sustained rise in rates would lift the embedded cost of capital in future rate cases and increase interest expense on new debt. Estimated probability: 40%. Impact: moderate.
- Lagging total returns versus the broader market: Trailing total returns as of 10 August 2026 trailed the S&P 500, indicating that sentiment-driven multiple compression or persistent underperformance could weigh on the share price even if operating results are stable. Estimated probability: 45%. Impact: low.
- Single-commission concentration in major rate-case outcomes: Although Exelon operates across multiple state jurisdictions, a materially adverse outcome in a principal rate case could disproportionately affect consolidated earnings and reset the perceived risk premium for the stock. Estimated probability: 30%. Impact: severe.
- Transmission project execution and cost recovery: The transmission-focused capital plan is the central growth driver, and cost overruns, permitting delays, or FERC formula-rate disputes could push out the in-service dates of projects that underpin rate-base growth. Estimated probability: 30%. Impact: moderate.
Who Should Own It / Avoid It
Ideal for: income-oriented, long-duration investors with a moderate risk tolerance who are seeking regulated-utility exposure, a current dividend yield of 3.59%, and a multi-year horizon over which the transmission capital programme can compound rate base. A minimum holding period of three to five years is appropriate to ride through individual rate-case cycles and the typical lag between capital deployment and revenue recognition under formula rates, and investors should be comfortable with the dilution profile of the ATM programme and the prospect of further equity issuance.
Avoid if: short-term capital-growth investors seeking to outperform the S&P 500, given that trailing total returns as of 10 August 2026 lagged the index and the P/E of 14.92 is consistent with a low-beta income name rather than a re-rating story. Investors who are unwilling to accept non-GAAP adjustments linked to regulatory matters, or who require a strict no-dilution policy, should also avoid given the USD 1.5 billion remaining under the 2025 Equity Distribution Agreement at 31 December 2025. Speculators looking for binary catalysts such as M&A or contract wins will not find them in the current evidence base.
Recommendation
BUY - 67/100. The recommendation reflects stable regulated earnings, a transmission-led capital programme, and a forward P/E of 14.92 that screens as undemanding against a 3.59% dividend yield, balanced against soft relative total returns and unresolved regulatory matters. An upgrade to a higher conviction tier would require a constructive named rate-case decision, evidence of accelerated transmission awards, or a re-rating in the multiple; a downgrade would follow an adverse regulatory order that materially impairs allowed ROE, a sharp rise in funding costs, or a step-up in ATM dilution beyond the 2023-2025 pace. At the current price of $40.73 the shares trade above our buy ceiling of $38.67: the thesis is credible but the price is not - new positions only below that level.
The probability-weighted value across our three scenarios is $44.16, 8% above the current price of $40.73 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below $38.67 - below this level the upside to the base-case target ($44.00) is at least 2x the downside to the bear case ($36.00), the minimum risk/reward we require before committing new capital.
between $38.67 and $44.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above $44.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 36%.
if an adverse regulatory ruling from a principal state commission or FERC that materially reduces allowed ROE, a cancellation or material delay of named transmission projects underpinning the capital plan, or a substantial acceleration of equity issuance beyond the USD 1.5 billion remaining under the 2025 Equity Distribution Agreement, regardless of price - the bear target of $36.00 is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 64/100. Trend versus prior report: Initiation.
| Report date | Conviction |
|---|---|
| 2026-10-04 | 67 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public news flow, company earnings press releases, regulatory filings, investor relations materials, and third-party earnings-date and quote pages were reviewed, including Yahoo Finance, Nasdaq, MarketBeat, Forbes, and the company's investor relations site. Analyst commentary on forward P/E and dividend yield was drawn from public quote pages; total-return data reflects the trailing figures published on 10 August 2026.
Primary source types: SEC filings on EDGAR (Form 10-K filed 12 February 2026; Form 8-K and related EX-99.1 filed 25 August 2026), company press releases and investor relations materials, earnings call transcripts and earnings release for the quarter reported 30 July 2026, and regulatory rate-case and FERC-related disclosures cited in the company's filings.
Key sources
- Exelon Reports Fourth Quarter and Full Year 2025 Results and Initiates 2026 Financial Outlook
- Exelon (EXC) Earnings Date and Reports 2026 $EXC
- Exelon Corporation (EXC) Stock Price, News, Quote & History - Yahoo Finance
- Exelon Announces Key Leadership Position Changes
- Exelon (EXC) Stock Price & Overview
- Exelon Stock Q1 2026: A $41.7 Billion Capital Pivot and a 47% Total Return Case | TIKR.com
- Exelon Corp (EXC) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles and Data ...
- Exelon Corporation | Energy you can count on
- exc-20260220
- After acquiring 6 stock-linked units, Exelon (EXC) director Lillie holds 3,941.
Data correct as of 2026-10-04